MXBIODEVICES
MxBiodevices was founded in August 2009 specifically to commercialize an injectable nano scaffold, E-Matrix, for the treatment of diabetic foot ulcers (DFU’s) and other chronic wounds. The company's founders were instrumental in E-Matrix development over the last 12 plus years, which led to 6 commercially successful E-Matrix products in orthopedics and spine. In February 2012 MxBiodevices obtained the exclusive license for E-Matrix treatment of all chronic wounds including DFU’s, decubitus ulcers, venous stasis ulcers, and surgical adhesions. The company has completed two FDA IDE clinical studies of E-Matrix treatment of DFU’s.
MXBIODEVICES
Social Links:
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2009-01-01
Address:
Greenville, North Carolina, United States
Country:
United States
Website Url:
http://www.mxbiodevices.com
Total Employee:
1+
Status:
Active
Contact:
252-551-5511
Email Addresses:
[email protected]
Total Funding:
210 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible GoDaddy DNS Google Google Cloud OpenResty Google Adsense GoDaddy Email Google Cloud Global Multi-Region AdBlock Acceptable Ads
Similar Organizations
Control Medical Technology
Control Medical Technology develops and commercializes patient care devices for physicians, nurses, and technicians.
CytoSolv
CytoSolv develops technology for the treatment of diabetic ulcers and other wounds.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Intralink-Spine
Intralink-Spine manufactures and commercializes an injectable medical device to treat spinal disc degeneration and low back pain.
Current Employees Featured
Founder
More informations about "MxBiodevices"
MxBiodevices - Crunchbase Company Profile & Funding
MxBiodevices was founded in August 2009 specifically to commercialize an injectable nano scaffold, E-Matrix, for the treatment of diabetic foot ulcers (DFU’s) and other chronic wounds. …See details»
MxBiodevices Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for MxBiodevices. Use the PitchBook Platform to explore the full profile.See details»
MxBiodevices Company Profile | Management and Employees List
MxBiodevices is commercializing a patented injectable bioscaffold, "DermagridTM", for the treatment of chronic dermal wounds including diabetic foot ulcers (DFUs), decubitus ulcers …See details»
Company Information - RocketReach
MxBiodevices, LLC was founded in August 2009 specifically to commercialize an injectable nanoscaffold, E-Matrix, for the treatment of diabetic foot ulcers (DFU’s) and other chronic …See details»
MxBiodevices - Overview, News & Similar companies - ZoomInfo
MxBiodevices is commercializing a patented injectable bioscaffold, "DermagridTM", for the treatment of chronic dermal wounds including diabetic foo t ulcers (DFUs), decubitus ulcers …See details»
MxBiodevices - Contacts, Employees, Board Members, Advisors
Mx Biodevices develops and commercializes an injectable nanoscaffold for the treatment of diabetic foot ulcers and other chronic wounds.See details»
MxBiodevices - Products, Competitors, Financials, Employees ...
MxBiodevices commercializes an injectable nanoscaffold, E-Matrix, for the treatment of diabetic foot ulcers (DFU's) and other chronic wounds. Use the CB Insights Platform to explore …See details»
MxBiodevices - Funding, Financials, Valuation & Investors
Mx Biodevices develops and commercializes an injectable nanoscaffold for the treatment of diabetic foot ulcers and other chronic wounds.See details»
MxBiodevices | EquityNet
Dr. Ronald Hill, Dr. Francis Lamberti and Ms. Marilyn Thompson founded MxBiodevices specifically to commercialize an injectable bioscaffold to treat Diabetic Foot Ulcers (DFUs) and …See details»
MxBiodevices - VentureRadar
MxBiodevices VentureRadar profile. Find out more about MxBiodevices including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
MxBiodevices Stock Price, Funding, Valuation, Revenue & Financial ...
See MxBiodevices funding rounds, investors, investments, exits and more. Evaluate their financials based on MxBiodevices's post-money valuation and revenue.See details»
MxBiodevices - Tech Stack, Apps, Patents & Trademarks
Mx Biodevices develops and commercializes an injectable nanoscaffold for the treatment of diabetic foot ulcers and other chronic wounds.See details»
Dr. Ronald Hill | AgNovos Bioscience
Hill then founded MxBiodevices, where, as CEO and managing partner, he was responsible for all technology commercialization efforts, fund raising, partnering, and overall company …See details»
Revolutionary Diabetic Ulcer Treatment Headed to Market
MxBiodevices, a Greenville, NC biotech company has received a $30,000 Company Inception Loan from the North Carolina Biotechnology Center to aid in completing its business plan. …See details»
MxBiodevices Release: Revolutionary Diabetic Ulcer Treatment
Jun 12, 2012 · MxBiodevices is on the fast track to the European marketplace and eventual commercialization in the US with a revolutionary new treatment for diabetic foot ulcers (DFU). …See details»
MxBiodevices Develops Diabetic Foot Ulcer Treatment - Pitt …
Aug 6, 2012 · MxBiodevices is on the fast track to the European marketplace and eventual commercialization in the United States with a revolutionary new treatment for diabetic foot …See details»
MxBiodevices - Crunchbase
Mx Biodevices develops and commercializes an injectable nanoscaffold for the treatment of diabetic foot ulcers and other chronic wounds.See details»
MXBiodevices, NIRVana Vie for NC IDEA Grants
Oct 2, 2013 · Greenville-based MxBiodevices, started in 2009 and boosted in 2012 by a $50,000 Company Inception Loan from the North Carolina Biotechnology Center, was among those …See details»
Marilyn Thompson - Co-founder @ MxBiodevices - Crunchbase
Marilyn Thompson is the Co-Founder at MxBiodevices.See details»
Wound healing company MxBiodevices seeks $8M for diabetic …
Feb 27, 2013 · Wound healing company MxBiodevices is on the hunt for $8 million to take its experimental treatment for diabetic foot ulcers through pivotal clinical trials.The Greenville, NC …See details»